KY SB 307
died on adjournmentAN ACT relating to step therapy protocols.
Kentucky · 2026 Regular Session · upper
Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.
Quick answers
Did KY SB 307 pass?
No. KY SB 307 died when the 2026 Regular Session adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2026-02-27): to Committee on Committees (S)
What is KY SB 307 about?
Amend KRS 304.17A-163 to modify the definition of "health plan"; require insurers, health plans, private review agents, and pharmacy benefit managers to disclose certain information about step therapy protocols on their website and ensure that the electronic process for requesting and transmitting prior authorization for a drug includes the ability for prescribing providers to electronically transmit a complete request for a step therapy exception; require coverage for a prescription drug on the date the provider submits a step therapy exception request; provide that requirements apply to Medicaid and KCHIP benefits to the extent authorized by federal law; require the Cabinet for Health and Family Services or the Department for Medicaid Services to seek federal approval if it is determined that such approval is necessary; provide authorization from the General Assembly to make changes in the Medicaid program as required under KRS 205.5372(1); provide that the Act applies to policies, certificates, contracts, and plans issued or renewed on or after the effective date of the Act.
Who sponsors KY SB 307?
K. Berg is the primary sponsor of KY SB 307.
Description
Amend KRS 304.17A-163 to modify the definition of "health plan"; require insurers, health plans, private review agents, and pharmacy benefit managers to disclose certain information about step therapy protocols on their website and ensure that the electronic process for requesting and transmitting prior authorization for a drug includes the ability for prescribing providers to electronically transmit a complete request for a step therapy exception; require coverage for a prescription drug on the date the provider submits a step therapy exception request; provide that requirements apply to Medicaid and KCHIP benefits to the extent authorized by federal law; require the Cabinet for Health and Family Services or the Department for Medicaid Services to seek federal approval if it is determined that such approval is necessary; provide authorization from the General Assembly to make changes in the Medicaid program as required under KRS 205.5372(1); provide that the Act applies to policies, certificates, contracts, and plans issued or renewed on or after the effective date of the Act.
- Introduced
- 2026-02-27
- Latest action
- 2026-02-27 — to Committee on Committees (S)
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- K. Bergprimary
Committees
Not provided by source.
Action timeline
Newest first
2026-02-27
to Committee on Committees (S)
referral-committee
2026-02-27
introduced in Senate
introduction
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:22:24.357326Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=KY&identifier=SB 307. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.